EADV Podcast

E42: Changing Treatment Landscape in Psoriasis

This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease.
 
Links to the six articles discussed can be found here:
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY)
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion inmoderate-to-severe plaque psoriasis: phase 3 open-label study
Itch: an under-recognized problem in psoriasis

E41: Editor‘s Picks October 2021

Join us as we go through the JEADV Editor's Picks of October 2021:
(1) Are skin types equally represented in Scandinavian dermatology textbooks?
(2) Apremilast for palmoplantar pustulosis under study
(3) The link between autoimmune bullous diseases and neurological diseases
(4) Investigating the cancer risk of using a biologic drug in atopic dermatitis
Read the editor's picks here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17616

E40: Pemphigus Vulgaris and Foliaceus: Latest management advancements

This week esteemed Professor Branka Marinović shares her experience as Secretary General of the EADV (2017-2021) and reflects on some significant ways how the Academy has changed in the past years. Join us as Prof. Marinovic talks about how the “Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus” facilitated the everyday work of Dermatologists and improved quality of care. Finally, the importance of collaboration between the Autoimmune Blistering Diseases Task Force of the EADV and patient organizations is also highlighted.
 
The guidelines can be read here: Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the EADV

E39: Life on the Ocean Wave: Success of a targeted skin cancer screening programme

This month we discuss a recent publication reporting on the success of a targeted skin cancer screening initiative at a sailing festival with author Professor Khosrotehrani, a clinician-scientist and dermatologist at the University of Queensland, and the Diamantina Institute, Brisbane. Listen as moderator Dr Sarah Walsh explores the challenges and implications of delivering such a screening programme in the unique location of Hamilton Island, off the coast of Queensland.
 
Read all about this interesting subject here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17062
 
💡Did you know that a subscription to the high-impact factor JEADV is included in the EADV Membership?

E38: Editor’s Picks September 2021

Join us as we go through the JEADV Editor's Picks of September 2021:
(1) Promising debut for a new botulinum toxin
(2) Does atopic dermatitis impact future education levels?
(3) Beyond histamine: itch in scabies
(4) Mental health and treatment response of anogenital warts: a prospective study
Read the editor's picks here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17528

E37: Meet EADV President, Prof. Alexander Stratigos

In the run-up to the 30th Congress of the European Academy of Dermatology and Venereology, Prof Alexander Stratigos, talks about the accomplishments of the Academy in his first year as President and the challenges and opportunities brought about by the COVID-19 pandemic that have paved the way to a digital transformation and a strengthened voice in Europe.

E36:Vulva Dermatology Part II: Lichen planus and lichen sclerosus

Lichen Planus and Lichen sclerosus are two conditions that affect the vulva. Due to popular request, this week we will revisit the a webcast where Dr Fiona Lewis brings practical clinical experience focusing on diagnosis and basic management of these conditions.

E35: Editor's Picks August 2021

Join us as we go through the JEADV Editor's Picks of August 2021:
(1) Genetic advances in treating epidermolysis bullosa(2) Searching for a tolerable topical treatment of primary axillary hyperhidrosis(3) RASopathies and the importance of skin examinations(4) Molecular testing of tinea
Read the Editor's Picks here